RPT-FDA rejects AstraZeneca move on generic Seroquel

LONDON, March 9 (Reuters) - U.S. regulators have
rejected a move by AstraZeneca that could have delayed
the entry of generic versions of its top-selling antipsychotic
Seroquel onto the U.S. market later this month.

water damage cleanup atlanta paris plumbing seattle teco engineering